Related Experiment Video
Updated: Jul 18, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Diagnostic criteria in well-differentiated thyroid carcinomas.
Elsa Fonseca1, Paula Soares, Manuel Cardoso-Oliveira
1Department of Pathology, Medical Faculty of the University of Porto, Porto, Portugal.
Endocrine Pathology
|December 13, 2006
Summary
This review details diagnostic criteria for well-differentiated thyroid tumors from follicular cells, including architectural, immunohistochemical, and molecular features. It covers common types and newly identified borderline lesions for accurate classification.
Area of Science:
- Endocrinology
- Surgical Pathology
- Oncology
Background:
- Accurate diagnosis of well-differentiated thyroid tumors is crucial for appropriate patient management.
- Follicular cell-derived thyroid neoplasms present diagnostic challenges, particularly distinguishing benign from malignant entities.
- Recent advances necessitate updated criteria for classifying these tumors.
Purpose of the Study:
- To review and consolidate diagnostic criteria for well-differentiated thyroid tumors of follicular cell origin.
- To highlight key architectural, immunohistochemical, and molecular features for differential diagnosis.
- To discuss recently described borderline lesions with uncertain malignant potential.
Main Methods:
- Comprehensive literature review of diagnostic criteria for thyroid tumors.
- Analysis of architectural, immunohistochemical, and molecular markers.
- Focus on differentiating follicular carcinoma, papillary carcinoma, follicular variant, and oncocytic tumors.
- Inclusion of borderline lesions: tumors of uncertain malignant potential and not otherwise specified carcinomas.
Main Results:
- Established criteria integrate morphological and molecular data for precise tumor classification.
- Key features differentiating follicular carcinoma from adenoma are detailed.
- Diagnostic challenges and features of papillary carcinoma and its variants are elucidated.
- Oncocytic (Hürthle cell) tumors and recently defined borderline lesions are characterized.
Conclusions:
- A multi-faceted approach combining histology, immunohistochemistry, and molecular data is essential for accurate thyroid tumor diagnosis.
- Clear diagnostic criteria aid in distinguishing malignant thyroid tumors from benign lesions and borderline entities.
- Standardized classification improves patient stratification and treatment strategies for thyroid neoplasms.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...